English
This article is from The Journal of Biological Chemistry , volume 287 . Abstract Background: Mutations in the ALK2 kinase cause extraskeletal bone formation.Results: We solved the structure of ALK2 in complex with the inhibitor FKBP12.Conclusion: Disease mutations break critical interactions that stabilize the inactive ALK2-FKBP12 complex leading to kinase activation.Significance: We offer an explanation for the effects of mutation and a structural template for the design of small molecule inhibitors.
Sign in with your free account to read, download EPUBs or listen.
Ebook · Structure of the Bone Morphogenetic Protein Receptor ALK2 and Implications for Fibrodysplasia Ossificans Progressiva*. · Chaikuad, Apirat, Alfano, Ivan, Kerr, Georgina, Sanvitale, Caroline E., Boergermann, Jan H., Triffitt, James T., von Delft, Frank, Knapp, Stefan · Internet Archive